Literature DB >> 21067463

Tissue transglutaminase 2 promotes apoptosis of rat neonatal cardiomyocytes under oxidative stress.

Heesang Song1, Byoung-Keuk Kim, Woochul Chang, Soyeon Lim, Byeong-Wook Song, Min-Ji Cha, Yangsoo Jang, Ki-Chul Hwang.   

Abstract

The role of tissue transglutaminase 2 (TG2) in cardiac myocyte apoptosis under oxidative stress induced by ischemic injury remains unclear. Here, we investigated the effects of TG2 on apoptosis of cardiomyocytes under oxidative stress. Ectopic expression of TG2 increased caspase-3 activity and calcium overload in cardiomyocytes. Expression levels of TG2 were significantly increased in H(2)O(2)-treated cardiomyocytes. Caspase-3 activity assay demonstrated its considerable correlation with TG2 expression, which supported that caspase-3 inhibitor inhibited the apoptosis induced by the ectopic overexpression of TG2. In addition, the other apoptotic signals, such as caspase-8, cytochrome c, and Bax, were increased dependent with TG2 expression in H(2)O(2)-treated cardiomyocytes. These results indicated that apoptotic signals had a positive correlation with TG2 expression. The decreased expression of phospholipase C (PLC)-δ1 and phospho-PKC in H(2)O(2)-treated cardiomyocytes were rescued by TG2 silencing. Together, our data strongly suggest that oxidative stress up-regulates TG2 expression in cardiomyocytes, leading to apoptosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21067463     DOI: 10.3109/10799893.2010.529577

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  6 in total

1.  Proteomic and transcriptomic analysis of heart failure due to volume overload in a rat aorto-caval fistula model provides support for new potential therapeutic targets - monoamine oxidase A and transglutaminase 2.

Authors:  Jiri Petrak; Jana Pospisilova; Miroslava Sedinova; Petr Jedelsky; Lucie Lorkova; Ondrej Vit; Michal Kolar; Hynek Strnad; Jan Benes; David Sedmera; Ludek Cervenka; Vojtech Melenovsky
Journal:  Proteome Sci       Date:  2011-11-11       Impact factor: 2.480

2.  Transglutaminase 2 promotes both caspase-dependent and caspase-independent apoptotic cell death via the calpain/Bax protein signaling pathway.

Authors:  Je-Ok Yoo; Young-Cheol Lim; Young-Myeong Kim; Kwon-Soo Ha
Journal:  J Biol Chem       Date:  2012-03-14       Impact factor: 5.157

3.  Modulation of transglutaminase 2 activity in H9c2 cells by PKC and PKA signalling: a role for transglutaminase 2 in cytoprotection.

Authors:  Ibtesam Almami; John M Dickenson; Alan J Hargreaves; Philip L R Bonner
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

4.  Role of tissue transglutaminase in the pathogenesis of diabetic cardiomyopathy and the intervention effect of rutin.

Authors:  Hai-Cheng Gao; Kun Zhu; Hai-Mei Gao; Chun-Sheng Miao; LE-Ning Zhang; Wei Liu; Hua Xin
Journal:  Exp Ther Med       Date:  2015-01-28       Impact factor: 2.447

5.  Tissue transglutaminase induction in the pressure-overloaded myocardium regulates matrix remodelling.

Authors:  Arti V Shinde; Marcin Dobaczewski; Judith J de Haan; Amit Saxena; Kang-Kon Lee; Ying Xia; Wei Chen; Ya Su; Waqas Hanif; Inderpreet Kaur Madahar; Victor M Paulino; Gerry Melino; Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2017-07-01       Impact factor: 10.787

6.  C-peptide prevents hyperglycemia-induced endothelial apoptosis through inhibition of reactive oxygen species-mediated transglutaminase 2 activation.

Authors:  Mahendra Prasad Bhatt; Young-Cheol Lim; JongYun Hwang; SungHun Na; Young-Myeong Kim; Kwon-Soo Ha
Journal:  Diabetes       Date:  2012-08-24       Impact factor: 9.461

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.